Moreover, dapagliflozin treatment reduced the expression of hepatic inflammatory cytokine (TNF-α, IL-1β, IL-18) content and improved hepatic steatosis in HCHF fed male Wistar rats [130]. This evidence concerns the gene TNF and fatty liver disease.